In line with this, another study documented that PRMT1 was found to induce PGC-1α mRNA expression through the recruitment of HNF-4α to the promoter region of PGC-1α, thereby attenuating hepatic steatosis via enhancing PGC-1α-mediated fatty acid oxidation [33]. This evidence concerns the gene PPARGC1A and fatty liver disease.